Open Medicine Foundation®
Leading research. Delivering hope.
ME/CFS and related chronic complex diseases

News

Maximize Your Support For A Cure

As 2017 comes to a close, we want to say thank you for your past support and commitment to OMF’s research to cure ME/CFS and related chronic complex diseases. OMF relies solely on donations from people just like you…ordinary people sharing a common vision and goal. Amelie Hicks, her mother Candi Pastorek, and sister Mary Gelpi,…

Read More

Meet Dr. Mike Snyder, Chair of the Genetics Department at Stanford University and member of ME/CFS Collaborative Research Team

Happy #OMFScienceWednesday! Today we get to know the research of Dr. Mike Snyder, Chair of the Genetics Department at Stanford University, whose team is part of the ME/CFS Collaborative Research Center at Stanford that we are funding. Dr. Snyder is a pioneer in the area of using a variety of technologies to monitor the health of…

Read More

Collaborative Research Center at Stanford aims to produce blood-based diagnostic technology for ME/CFS

Happy #OMFScienceWednesday! Today, we talk about why the Collaborative Research Center at Stanford we are funding aims to produce blood-based diagnostic technology for ME/CFS. Here are three major reasons: 1) Cheaper and faster: Anyone familiar with ME/CFS knows how difficult, time-consuming, and expensive it is for patients to get a diagnosis. A big part of that…

Read More

OMF grants $1.2 million to Ramp Up Collaborative Research Center at Stanford University

Open Medicine Foundation is funding a Collaborative Research Center! The ME/CFS Collaborative Research Center at Stanford will be led by Dr. Ron Davis, Professor of Biochemistry and Genetics at Stanford University, and Director of our Scientific Advisory Board. Dr. Davis has assembled a truly world-class team of researchers, many of whom have never before focused…

Read More

The study of gene expression in ME/CFS by measuring RNA in patient samples

On this #OMFScienceWednesday, we look at why it is interesting to study gene expression in ME/CFS by measuring RNA in patient samples. Genes – made up of DNA – are expressed as RNA to accomplish their functions in the cell, often by being translated into proteins. The amount of RNA expressed from each gene is regulated…

Read More

BU News Service: A Problem Coffee Cannot Fix; Boston Community Comes Together for ME/CFS

by Sarah Wells “Imagine you had the worst flu ever, but it never went away,” said Linda Tannenbaum, a clinical laboratory scientist, to a crowd gathered at Newton-Wellesley hospital earlier this month for a research update. She was describing Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, more commonly referred to as just “Chronic Fatigue Syndrome.” Despite its mild-sounding name, Chronic…

Read More

Scope: Personalized Health Conference cultivates international, interdisciplinary collaborations

Author: Raeka Aiyar, PhD “Every one of us has a passion to improve human health,” said Lloyd Minor, MD, dean of Stanford’s medical school, as he welcomed participants to the Personalized Health Conference held here earlier this month. “And it’s important to remember that in the end, research is about the people. We must always find…

Read More

OMF Joins UNREST to Host HOUSE PARTIES Around the World

With the broadcast of Unrest on the US PBS/Independent Lens coming January 8th, now is your opportunity to share the film with friends, colleagues, and family members that don’t know much about ME/CFS or want to know what else they can do! This is a great way to get more folks to inspired to support OMF’s research! Time for Unrest…

Read More

SGTC Research Conference Includes Focus On ME/CFS

 #OMFScienceWednesday share the highlights from this week’s Stanford Genome Technology Center (SGTC) research conference, an annual event where Dr. Ron Davis’ team assembles to share their results and discuss the future of their research. An entire session was dedicated to ME/CFS research, with additional sessions on SGTC’s core work in synthetic biology, genomics approaches to disease, and…

Read More

OMF’s Linda Tannenbaum is “Partnering for Faster Cures” in San Francisco

Today Linda is meeting at the Partnering for Cures conference in San Francisco with leaders and decision-makers from across diseases who are motivated by the same mission – to transform the medical research system and reduce time and cost of getting new therapies from discovery to patients: “I’m attending Partnering for Cures to make connections,…

Read More